1 Barben J, Hammer J. Behandlung der Bronchiolitis im Säuglingsalter – Empfehlungen der SAPP. PAEDIATRICA. 2003;14:18–21.
2 Barben J, Hammer J. Behandlung der akuten Bronchiolits im Säuglingsalter. Schweiz Med Forum. 2004;4:251–253.
3 Scottish Intercollegiate Guidelines Network SIGN). Bronchiolitis in children. 2006. Available from: http://www.fimpmarche.it/attivita-di-formazione/documenti-attivita-di-formazione/linee-guida/12-bronchioliti-2006/file.
4 Turner T, Wilkinson F, Harris C, Mazza D, Health for Kids Guideline Development Group. Evidence based guideline for the management of bronchiolitis. Aust Fam Physician. 2008;376):6–13.
5 Verstraete M, Cros P, Gouin M, Oillic H, Bihouée T, Denoual H et al. Update on the management of acute viral bronchiolitis: proposed guidelines of Grand Ouest University Hospitals [Article in French]. Arch Pediatr. 2014;21(1):53–62.
6 Friedman JN, Rieder MJ, Walton JM, Canadian Paediatric Society ACCDTaHSC. Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014;19(9):485–498.
7 Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pedatrics. 2014;134(5):e1474-e1502.
8 Baraldi E, Lanari M, Manzoni P, Rossi GA, Vandini S, Rimini A et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr. 2014;40:65.
9 National Institute for Health and Care Excellence (NICE). Bronchiolitis in children: diagnosis and management.
https://www nice org uk/guidance/ng9 [ 2015 NICE guideline [NG9]
10 Agyeman P, Barazzone-Argiroffo C, Hammer J, Heininger U, Nadal D, Pfammatter JP et al. Prävention von RSV-Infektionen mit dem humanisierten monoklonalen Antikörper Palivizumab. Schweiz Med Forum. 2017;17:611–4.
11 Meissner HC. Viral Bronchiolitis in Children. N Engl J Med. 2016;374(1):62–72.
12 Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017;389:211–24.
13 Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98.
14 Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol. 2011;46(4):324–47.
15 Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970;23(1):7–18.
16 Mulholland EK, Olinsky A, Shann FA. Clinical findings and severity of acute bronchiolitis. Lancet. 1990;335:1259–61.
17 Frey U, von Mutius E. The challenge of managing wheezing in infants. N Engl J Med. 2009;360(20):2130–3.
18 Barben J, Kuehni CE. Hypertonic saline for acute viral bronchiolitis - take the evidence with a grain of salt. Eur Respir J. 2014;44:827–30.
19 Barben J, Kuehni CE, Trachsel D, Hammer J. Management of acute bronchiolitis – Can evidence-based guidelines alter clinical practice? Thorax. 2008;63:1103–9.
20 Fitzgerald DA, Kilham HA. Bronchiolitis: assessment and evidence-based management. Med J Aust. 2004;180(8):399–404.
21 Calogero C, Sly PD. Acute viral bronchiolitis: to treat or not to treat-that is the question. J Pediatr. 2007;151(3):235–7.
22 Hammer J. Die RSV-Infektion im Kindesalter. Schweiz Med Wochenschr. 1998;128:366–74.
23 Bekhof J, Bakker J, Reimink R, Wessels M, Langenhorst V, Brand PL et al. Co-infections in children hospitalised for bronchiolitis: role of roomsharing. J Clin Med Res. 2013;5(6):426–31.
24 Virrki R, Juven T, Rikalainen H, Svedström E, Mertesola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax. 2002;57:438–441.
25 Albinski M, Gämperli L, Regamey N, Stettler J, Tomaske M. Hyponatraemia in Paediatric Bronchiolitis – a Harmful Complication not to be Ignored. Klin Padiatr. 2016;228(5):275–6.
26 Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pedatrics. 2019;134(5):e1474-e1502.
27 Reynolds EOR, Cook CD. The treatment of bronchiolitis. J Pediatr. 1963;63:1205–7.
28 Everard ML, Bara A, Kurian M, Elliott TM, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev. 2005;3:CD001279).
29 Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;6:CD004878.
doi:10.1002/14651858.CD004878.pub4.
30 Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;6:CD001266.
31 Liu F, Ouyang J, Sharma AN, Liu S, Yang B, Xiong W et al. Leukotriene inhibitors for bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2015;3:CD010636.
doi:10.1002/14651858.CD010636.pub2.
32 Roqué i Figuls M, Giné-Garriga M, Granados Rugeles C, Perrotta C, Vilaró J. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev.2016;2:CD004873
doi:10.1002/14651858.CD004873.pub5.
33 Farley R, Spurling GK, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014; 10:CD005189.
doi: 10.1002/14651858.CD005189.pub4.
34 Kua KP, Lee SW. Complementary and alternative medicine for the treatment of bronchiolitis in infants: A systematic review. PLoS One 2017; 12(2):e0172289.
35 Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011;6:CD003123.
36 ERS Task Force:, Lenney W, Boner AL, Bont L, Bush A, Carlsen KH et al. Medicines used in respiratory diseases only seen in children. Eur Respir J. 2009;34(3):531–51.
37 Mussman GM, Parker MW, Statile A, Sucharew H, Brady PW. Suctioning and length of stay in infants hospitalized with bronchiolitis. JAMA Pediatr. 2019;167(5):414–21.
38 Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest. 2002;122(6):2015–10.
39 Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest. 2003;123(2):481–7.
40 Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med Assoc J. 2006;8(3):169–73.
41 Kuzik BA, Al-Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr. 2007;151(3):266–70.
42 Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2013;7:CD006458:
doi:10.1002/14651858.CD006458.pub3.
43 Jacobs JD, Foster M, Wan J, Pershad J. 7% Hypertonic saline in acute bronchiolitis: a randomized controlled trial. Pediatrics. 2014;133(1):e8-e13.
44 Florin TA, Shaw KN, Kittick M, Yakscoe S, Zorc JJ. Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial. JAMA Pediatr. 2014;168(7):664–70.
45 Wu S, Baker C, Lang ME, Schrager SM, Liley FF, Papa C et al. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2014;168(7):657–63.
46 Everard ML, Hind D, Ugonna K, Freeman J, Bradburn M, Cooper CL et al. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax. 2014;69(12):1105–12.
47 Teunissen J, Hochs AH, Vaessen-Verberne A, Boehmer AL, Smeets CC, Brackel H et al. The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J. 2014;44(4):913–21.
48 Angoulvant F, Bellêttre X, Milcent K, Teglas JP, Claudet I, Le Guen CG et al. Effect of Nebulized Hypertonic Saline Treatment in Emergency Departments on the Hospitalization Rate for Acute Bronchiolitis: A Randomized Clinical Trial. JAMA Pediatr. 2017;171(8):e171333.
49 Brooks CG, Harrison WN, Ralston SL. Association Between Hypertonic Saline and Hospital Length of Stay in Acute Viral Bronchiolitis: A Reanalysis of 2 Meta-analyses. JAMA Pediatr. 2016;170(6):577–84.
50 Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2017;12:CD006458.
doi:10.1002/14651858.CD006458.pub4.
51 Jaquet-Pilloud R, Verga ME, Russo M, Gehri M, Pauchard JY. Nebulised hypertonic saline in moderate-to-severe bronchiolitis: a randomised clinical trial. Arch Dis Child. 2019 Sep 5. pii: archdischild-2019–317160.
doi:10.1136/archdischild-2019–317160. [Epub ahead of print] .
52 Cunningham S, McMurray A. Observational study of two oxygen saturation targets for discharge in bronchiolitis. Arch Dis Child. 2012;97(4):361–3.
53 Cunningham S, Rodriguez A, Adams T, Boyd KA, Butcher I, Enderby B et al. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet. 2015;386(9998):1041–8.
54 McCulloh R, Koster M, Ralston S, Johnson M, Hill V, Koehn K et al. Use of Intermittent vs Continuous Pulse Oximetry for Nonhypoxemic Infants and Young Children Hospitalized for Bronchiolitis: A Randomized Clinical Trial. JAMA Pediatr. 2015;169(10):898–904.
55 Principi T, Coates AL, Parkin PC, Stephens D, DaSilva Z, Schuh S. Effect of Oxygen Desaturations on Subsequent Medical Visits in Infants Discharged From the Emergency Department With Bronchiolitis. JAMA Pediatr. 2016;170(6):602–8.
56 Moschino L, Mario F, Carraro S, Visentin F, Zanconato S, Baraldi E. Is nasal suctioning warranted before measuring O2 saturation in infants with bronchiolitis? Arch Dis Child. 2016;101(1):114–5.
57 Schibler A, Pham TM, Dunster KR, Foster K, Barlow A, Gibbons K et al. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med. 2011;37(5):847–52.
58 Arora B, Mahajan P, Zidan MA, Sethuraman U. Nasopharyngeal airway pressures in bronchiolitis patients treated with high-flow nasal cannula oxygen therapy. Pediatr Emerg Care. 2012;28(11):1179–84.
59 Hough JL, Pham TM, Schibler A. Physiologic effect of high-flow nasal cannula in infants with bronchiolitis. Pediatr Crit Care Med. 2014;15(5):e214–9.
60 Franklin D, Dalziel S, Schlapbach LJ, Babl FE, Oakley E, Craig SS et al. Early high flow nasal cannula therapy in bronchiolitis, a prospective randomised control trial (protocol): A Paediatric Acute Respiratory Intervention Study (PARIS). BMC Pediatr. 2015;15:183.
61 Pham TM, O’Malley L, Mayfield S, Martin S, Schibler A. The effect of high flow nasal cannula therapy on the work of breathing in infants with bronchiolitis. Pediatr Pulmonol. 2015;50(7):713–20.
62 Schlapbach LJ, Straney L, Gelbart B, Alexander J, Franklin D, Beca J et al. Burden of disease and change in practice in critically ill infants with bronchiolitis. Eur Respir J. 2017;49(6):pii: 1601648.
doi:10.1183/13993003.01648–2016.
63 Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J et al. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis. N Engl J Med. 2018;378(12):1121–31.
64 Oakley E, Borland M, Neutze J, Acworth J, Krieser D, Dalziel S et al. Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: a randomised trial. Lancet Respir Med. 2013;1(2):113–20.
65 Ankermann T, Schwerk N. Obstruktive Bronchitis. Kinder- und Jugendmedizin. 2012;2: 81–6.
66 Øymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Traum Resusc Emerg Med. 2014;22:23.